In December 2004, Philip Morabito sued Pfizer and Henry A. McKinnell, then Pfizer's board chair and chief executive officer, alleging two claims under the Securities and Exchange Act of 1934. On or about March 27, 2012, an amended complaint was filed that alleged that Pfizer and the individual defendants had made false representations and omissions regarding the cardiovascular risks associated with two of Pfizer's drugs: Celebrex and Bextra. (Photo: Daniel Acker/Bloomberg) In December 2004, Philip Morabito sued Pfizer and Henry A. McKinnell, then Pfizer's board chair and chief executive officer, alleging two claims under the Securities and Exchange Act of 1934. In 2012, an amended complaint was filed that alleged that Pfizer and the individual defendants had made false representations and omissions regarding the cardiovascular risks associated with two of Pfizer's drugs: Celebrex and Bextra. (Photo: Daniel Acker/Bloomberg)

A Delaware court has ruled that exclusions in insurance policies issued to Pfizer Inc. did not preclude coverage for the $568 million it agreed to pay to settle a securities fraud class action.

Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader

  • All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
  • Educational webcasts, resources from industry leaders, and informative newsletters.
  • Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Litigation